Literature DB >> 15044353

Minireview: Gut peptides regulating satiety.

Maralyn R Druce1, Caroline J Small, Stephen R Bloom.   

Abstract

The gastrointestinal tract and the pancreas release hormones regulating satiety and body weight. Ghrelin stimulates appetite, and glucagon-like peptide-1, oxyntomodulin, peptide YY, cholecystokinin, and pancreatic polypeptide inhibit appetite. These gut hormones act to markedly alter food intake in humans and rodents. Obesity is the current major cause of premature death in the United Kingdom, killing almost 1000 people per week. Worldwide, its prevalence is accelerating. There is currently no effective answer to the pandemic of obesity, but replacement of the low levels of peptide YY observed in the obese may represent an effective antiobesity therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044353     DOI: 10.1210/en.2004-0089

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  28 in total

1.  Impact of exercise and dietary fatty acid composition from a high-fat diet on markers of hunger and satiety.

Authors:  J A Cooper; A C Watras; C M Paton; F H Wegner; A K Adams; D A Schoeller
Journal:  Appetite       Date:  2010-10-28       Impact factor: 3.868

Review 2.  Pediatric endocrine disorders of energy balance.

Authors:  Robert H Lustig
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

Review 3.  Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism.

Authors:  Diego Perez-Tilve; Ruben Nogueiras; Federico Mallo; Stephen C Benoit; Matthias Tschoep
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

4.  Catheter-directed gastric artery chemical embolization suppresses systemic ghrelin levels in porcine model.

Authors:  Aravind Arepally; Brad P Barnett; Tarak H Patel; Tarek T Patel; Valerie Howland; Ray C Boston; Dara L Kraitchman; Ashkan A Malayeri
Journal:  Radiology       Date:  2008-10       Impact factor: 11.105

5.  A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study.

Authors:  S C Burnham; N G Faux; W Wilson; S M Laws; D Ames; J Bedo; A I Bush; J D Doecke; K A Ellis; R Head; G Jones; H Kiiveri; R N Martins; A Rembach; C C Rowe; O Salvado; S L Macaulay; C L Masters; V L Villemagne
Journal:  Mol Psychiatry       Date:  2013-04-30       Impact factor: 15.992

6.  Ileal effect on blood glucose, HbA1c, and GLP-1 in Goto-Kakizaki rats.

Authors:  Henry Buchwald; Hector J Menchaca; Van N Michalek; Nestor T Bertin
Journal:  Obes Surg       Date:  2014-11       Impact factor: 4.129

7.  Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study.

Authors:  François Mion; Rodica Gincul; Sabine Roman; Sylvain Beorchia; Frank Hedelius; Nicolas Claudel; Roger-Michel Bory; Etienne Malvoisin; Frédérique Trepo; Bertrand Napoleon
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

8.  Histopathologic and immunohistochemical sequelae of bariatric embolization in a porcine model.

Authors:  Ben E Paxton; Christopher L Alley; Jennifer H Crow; James Burchette; Clifford R Weiss; Dara L Kraitchman; Aravind Arepally; Charles Y Kim
Journal:  J Vasc Interv Radiol       Date:  2014-01-21       Impact factor: 3.464

9.  Sensitivity to the satiating effects of exendin 4 is decreased in obesity-prone Osborne-Mendel rats compared to obesity-resistant S5B/Pl rats.

Authors:  S D Primeaux; M J Barnes; H D Braymer; G A Bray
Journal:  Int J Obes (Lond)       Date:  2010-04-20       Impact factor: 5.095

Review 10.  Pathophysiology of obesity: why surgery remains the most effective treatment.

Authors:  Talat Waseem; Kris M Mogensen; David B Lautz; Malcolm K Robinson
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.